XML 35 R20.htm IDEA: XBRL DOCUMENT

Stockholders' Equity Transactions

12 Months Ended

Jun. 30, 2025

Stockholders' Equity Transactions

Stockholders' Equity Transactions

NOTE 11 – Stockholders’ Equity Transactions

Dividends

The following tables summarizes information about dividends declared by the Company for the Fiscal years ended June 30, 2025, 2024 and 2023:


Dividend Declaration Date		Stockholders of Record Date		Dividend Payable Date		Per Share Cash Dividend Amount

May 2, 2025		June 12, 2025		July 3, 2025		$ 0.14
January 30, 2025		March 12, 2025		April 3, 2025		$0.125
November 1, 2024		December 12, 2024		January 3, 2025		$0.125
August 22, 2024		September 12, 2024		October 3, 2024		$0.125
May 2, 2024		June 3, 2024		June 24, 2024		$ 0.10
February 1, 2024		March 1, 2024		March 22, 2024		$ 0.10
November 2, 2023		December 1, 2023		December 22, 2023		$ 0.08
August 18, 2023		September 1, 2023		September 22, 2023		$ 0.08
May 5, 2023		May 22, 2023		June 12, 2023		$0.0625

Common Shares Repurchases

On September 16, 2014 the Company’s board of directors authorized the repurchase of up to 2 million of the approximately 38.8 million shares of the Company’s common stock then outstanding. Such repurchases may be made from time to time in the open market or in privately negotiated transactions subject to market conditions and the market price of the common stock. In December of Fiscal 2018, the board of directors authorized the repurchase of up to an additional 1 million shares. In November of Fiscal 2025, the board authorized the repurchase of up to an additional 1 million shares. During the first quarter of the fiscal year ended June 30, 2025, the Company repurchased 193,252 shares of its outstanding common stock at a weighted average price of $37.67. During the second quarter of the fiscal year ended June 30, 2025, the Company repurchased 282,647 shares of its outstanding common stock at a weighted average price of $37.95. During the third quarter of the fiscal year ended June 30, 2025, the Company repurchased 745,000 shares of its outstanding common stock at a weighted average price of $25.22. Shares repurchased through the year ended June 30, 2025, are included in the Company’s Treasury Stock as of June 30, 2025. The Company currently has available 359,741 shares that can be repurchased under this authorization. There were no purchases of treasury shares for the years ended June 30, 2024 and 2023.

The following tables summarizes information about shares repurchased by the Company for the Fiscal year ended June 30, 2025:


						Total Number of		Maximum
		Total				Shares Purchased as		Number of Shares
		Number of		Average		Part of Publicly		that May Yet Be
		Shares		Price Paid		Announced Plans or		Purchased Under
Period		Purchased		per Share		Programs		Plans or Programs
September 10, 2024 - September 19, 2024		193,252		$ 37.67		193,252		1,387,388
November 7, 2024 - December 19, 2024		282,647		$ 37.95		282,647		1,104,741
February 6, 2025 - March 20, 2025		745,000		$ 25.22		745,000		359,741
Total for the Year ended June 30, 2025		1,220,899		$ 30.14		1,220,899		359,741

Stock Option Exercises

During fiscal 2025, certain employees and directors exercised stock options under the Company's 2012 Employee and 2020 Non-Employee Stock Option Plans totaling 5,000 shares. 3,000 of these exercises were completed as cashless exercises as allowed for under the plans, where the exercise shares are issued by the Company in exchange for shares of the Company's common stock that are owned by the optionees. The number of shares surrendered by the optionees was 2,151 and was based upon the aggregate fair market value on the date of the exercise equal to the purchase price being paid.

During fiscal 2024, certain employees and directors exercised stock options under the Company's 2012 Employee and 2018 Non-Employee Stock Option Plans totaling 153,644 shares. 115,644 of these exercises were completed as cashless exercises as allowed for under the plans, where the exercise shares are issued by the Company in exchange for shares of the Company's common stock that are owned by the optionees. The number of shares surrendered by the optionees was 49,270 and was based upon the aggregate fair market value on the date of the exercise equal to the purchase price being paid.

During fiscal 2023, certain employees and directors exercised stock options under the Company's 2012 Employee and 2018 Non-Employee Stock Option Plans totaling 53,000 shares. 43,600 of these exercises were completed as cashless exercises as allowed for under the plans, where the exercise shares are issued by the Company in exchange for shares of the Company's common stock that are owned by the optionees. The number of shares surrendered by the optionees was 17,385 and was based upon the aggregate fair market value on the date of the exercise equal to the purchase price being paid.